» Articles » PMID: 20887549

Differentiation of Bone Marrow-derived Mesenchymal Stem Cells into Hepatocyte-like Cells in an Alginate Scaffold

Overview
Journal Cell Prolif
Date 2010 Oct 5
PMID 20887549
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Alginate scaffolds are the most frequently investigated biomaterials in tissue engineering. Tissue engineering techniques that generate liver tissue have become important for treatment of a number of liver diseases and recent studies indicate that bone marrow-derived stem cells (BMSCs) can differentiate into hepatocyte-like cells. The goal of the study described here, was to examine in vitro hepatic differentiation potential of BMSCs cultured in an alginate scaffold.

Materials And Methods: To investigate the potential of BMSCs to differentiate into hepatocyte-like cells, we cultured BMSCs in alginate scaffolds in the presence of specific growth factors including hepatocyte growth factor, epidermal growth factor and fibroblast growth factor-4.

Results: We can demonstrate that alginate scaffolds are compatible for growth of BMSCs and when cultured in alginate scaffolds for several days they display several liver-specific markers and functions. Specifically, they expressed genes encoding alpha-foetoprotein, albumin (ALB), connexin 32 and CYP7A1. In addition, these BMSCs produced both ALB and urea, expressed cytokeratin-18 (CK-18) and were capable of glycogen storage. Percentage of CK-18 positive cells, a marker of hepatocytes, was 56.7%.

Conclusions: Our three-dimensional alginate scaffolds were highly biocompatible with BMSCs. Furthermore, culturing induced their differentiation into hepatocyte-like cells. Therefore, BMSCs cultured in alginate scaffolds may be applicable for hepatic tissue engineering.

Citing Articles

Scaffold-mediated liver regeneration: A comprehensive exploration of current advances.

Bhatt S S, Krishna Kumar J, Laya S, Thakur G, Nune M J Tissue Eng. 2024; 15:20417314241286092.

PMID: 39411269 PMC: 11475092. DOI: 10.1177/20417314241286092.


Stem Cell-Based Strategies: The Future Direction of Bioartificial Liver Development.

Feng L, Wang Y, Fu Y, Li T, He G Stem Cell Rev Rep. 2024; 20(3):601-616.

PMID: 38170319 DOI: 10.1007/s12015-023-10672-5.


Application of three-dimensional cell culture technology in screening anticancer drugs.

Sun Y, Ma H Biotechnol Lett. 2023; 45(9):1073-1092.

PMID: 37421554 DOI: 10.1007/s10529-023-03410-x.


Biomaterial-based cell delivery strategies to promote liver regeneration.

Ali M, Payne S Biomater Res. 2021; 25(1):5.

PMID: 33632335 PMC: 7905561. DOI: 10.1186/s40824-021-00206-w.


Urine-derived stem cells accelerate the recovery of injured mouse hepatic tissue.

Hu C, He Y, Fang S, Tian N, Gong M, Xu X Am J Transl Res. 2020; 12(9):5131-5150.

PMID: 33042410 PMC: 7540109.


References
1.
Panduro A, Shalaby F, Weiner F, BIEMPICA L, Zern M, Shafritz D . Transcriptional switch from albumin to alpha-fetoprotein and changes in transcription of other genes during carbon tetrachloride induced liver regeneration. Biochemistry. 1986; 25(6):1414-20. DOI: 10.1021/bi00354a034. View

2.
Jiankang H, Dichen L, Yaxiong L, Bo Y, Hanxiang Z, Qin L . Preparation of chitosan-gelatin hybrid scaffolds with well-organized microstructures for hepatic tissue engineering. Acta Biomater. 2008; 5(1):453-61. DOI: 10.1016/j.actbio.2008.07.002. View

3.
Rubin J, Bottaro D, Aaronson S . Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product. Biochim Biophys Acta. 1993; 1155(3):357-71. DOI: 10.1016/0304-419x(93)90015-5. View

4.
Hari P, Chandy T, Sharma C . Chitosan/calcium alginate microcapsules for intestinal delivery of nitrofurantoin. J Microencapsul. 1996; 13(3):319-29. DOI: 10.3109/02652049609026019. View

5.
Smidsrod O, Skjak-Braek G . Alginate as immobilization matrix for cells. Trends Biotechnol. 1990; 8(3):71-8. DOI: 10.1016/0167-7799(90)90139-o. View